Table 2.

Adverse events

	Control	AdVEGF-D	OR (95% CI)	P-value
	n = 6	n = 24
Major complications
Death	0 (0)	3 (13)	2.12 (0.10–46.53)	0.50
During 14-day follow-up	0 (0)	1 (4)	0.83 (0.03–22.87)	0.80
ACS or MI	1 (17)	3 (13)	0.65 (0.06–7.64)	0.61
During 14-day follow-up	0 (0)	0 (0)	0.27 (0.00–14.69)	1.00
Stroke	0 (0)	2 (8)	1.47 (0.06–34.50)	0.63
During 14-day follow-up	0 (0)	1 (4)	0.83 (0.03–22.87)	0.80
MACE	1 (17)	8 (33)	2.50 (0.25–25.25)	0.40
Other complications
Minor bleeding	2 (33)	9 (38)	1.20 (0.18, 7.93)	0.62
Procedural complications	1 (17)	1 (4)	0.22 (0.01, 4.09)	0.37
New atrial fibrillation	0 (0)	1 (4)	0.83 (0.03, 22.87)	0.80
Pericardial effusion	1 (17)	7 (29)	2.06 (0.20, 20.96)	0.48
During 14-day follow-up	0 (0)	5 (21)	3.67 (0.18–75.75)	0.30

Values are n (%). MACE = combined end point of death, ACS, MI, or stroke.

ACS, acute coronary syndrome; CI, confidence interval; MACE, major adverse cardiovascular event; MI, myocardial infarction; OR, odds ratio.